Logo image of BMI

BADGER METER INC (BMI) Stock Fundamental Analysis

USA - NYSE:BMI - US0565251081 - Common Stock

186.19 USD
+3.11 (+1.7%)
Last: 11/5/2025, 8:04:00 PM
186.19 USD
0 (0%)
After Hours: 11/5/2025, 8:04:00 PM
Fundamental Rating

7

BMI gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. BMI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, BMI is valued expensive at the moment. These ratings could make BMI a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

BMI had positive earnings in the past year.
BMI had a positive operating cash flow in the past year.
Each year in the past 5 years BMI has been profitable.
Each year in the past 5 years BMI had a positive operating cash flow.
BMI Yearly Net Income VS EBIT VS OCF VS FCFBMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

BMI's Return On Assets of 14.19% is amongst the best of the industry. BMI outperforms 92.74% of its industry peers.
BMI has a better Return On Equity (19.75%) than 88.71% of its industry peers.
BMI has a better Return On Invested Capital (16.43%) than 91.94% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BMI is significantly above the industry average of 9.51%.
The last Return On Invested Capital (16.43%) for BMI is above the 3 year average (15.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.19%
ROE 19.75%
ROIC 16.43%
ROA(3y)13.08%
ROA(5y)12.25%
ROE(3y)17.86%
ROE(5y)16.46%
ROIC(3y)15.23%
ROIC(5y)14.23%
BMI Yearly ROA, ROE, ROICBMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 15.40%, BMI belongs to the best of the industry, outperforming 93.55% of the companies in the same industry.
BMI's Profit Margin has improved in the last couple of years.
BMI's Operating Margin of 19.93% is amongst the best of the industry. BMI outperforms 96.77% of its industry peers.
In the last couple of years the Operating Margin of BMI has grown nicely.
With a decent Gross Margin value of 41.26%, BMI is doing good in the industry, outperforming 70.16% of the companies in the same industry.
BMI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.93%
PM (TTM) 15.4%
GM 41.26%
OM growth 3Y7.03%
OM growth 5Y5.49%
PM growth 3Y7.84%
PM growth 5Y6.34%
GM growth 3Y-0.7%
GM growth 5Y0.68%
BMI Yearly Profit, Operating, Gross MarginsBMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

BMI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BMI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BMI has been increased compared to 5 years ago.
There is no outstanding debt for BMI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BMI Yearly Shares OutstandingBMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BMI Yearly Total Debt VS Total AssetsBMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 14.58 indicates that BMI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 14.58, BMI belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
There is no outstanding debt for BMI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.58
ROIC/WACC1.79
WACC9.17%
BMI Yearly LT Debt VS Equity VS FCFBMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

BMI has a Current Ratio of 3.22. This indicates that BMI is financially healthy and has no problem in meeting its short term obligations.
BMI has a Current ratio of 3.22. This is in the better half of the industry: BMI outperforms 66.13% of its industry peers.
A Quick Ratio of 2.23 indicates that BMI has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.23, BMI is doing good in the industry, outperforming 62.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 2.23
BMI Yearly Current Assets VS Current LiabilitesBMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.63% over the past year.
BMI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.16% yearly.
Looking at the last year, BMI shows a quite strong growth in Revenue. The Revenue has grown by 12.11% in the last year.
The Revenue has been growing by 14.25% on average over the past years. This is quite good.
EPS 1Y (TTM)16.63%
EPS 3Y26.69%
EPS 5Y21.16%
EPS Q2Q%10.19%
Revenue 1Y (TTM)12.11%
Revenue growth 3Y17.83%
Revenue growth 5Y14.25%
Sales Q2Q%13.06%

3.2 Future

The Earnings Per Share is expected to grow by 12.18% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.30% on average over the next years. This is quite good.
EPS Next Y13.79%
EPS Next 2Y13.14%
EPS Next 3Y10.48%
EPS Next 5Y12.18%
Revenue Next Year12.3%
Revenue Next 2Y10.4%
Revenue Next 3Y8.55%
Revenue Next 5Y9.3%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BMI Yearly Revenue VS EstimatesBMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
BMI Yearly EPS VS EstimatesBMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 39.61, the valuation of BMI can be described as expensive.
BMI's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.13, BMI is valued quite expensively.
A Price/Forward Earnings ratio of 34.39 indicates a quite expensive valuation of BMI.
BMI's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.35. BMI is valued rather expensively when compared to this.
Industry RankSector Rank
PE 39.61
Fwd PE 34.39
BMI Price Earnings VS Forward Price EarningsBMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BMI.
BMI's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BMI is cheaper than 71.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.99
EV/EBITDA 24.33
BMI Per share dataBMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of BMI may justify a higher PE ratio.
PEG (NY)2.87
PEG (5Y)1.87
EPS Next 2Y13.14%
EPS Next 3Y10.48%

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.88%, BMI is not a good candidate for dividend investing.
BMI's Dividend Yield is rather good when compared to the industry average which is at 2.07. BMI pays more dividend than 84.68% of the companies in the same industry.
With a Dividend Yield of 0.88, BMI pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.88%

5.2 History

The dividend of BMI is nicely growing with an annual growth rate of 13.80%!
BMI has been paying a dividend for at least 10 years, so it has a reliable track record.
BMI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.8%
Div Incr Years18
Div Non Decr Years18
BMI Yearly Dividends per shareBMI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

30.10% of the earnings are spent on dividend by BMI. This is a low number and sustainable payout ratio.
BMI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.1%
EPS Next 2Y13.14%
EPS Next 3Y10.48%
BMI Yearly Income VS Free CF VS DividendBMI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
BMI Dividend Payout.BMI Dividend Payout, showing the Payout Ratio.BMI Dividend Payout.PayoutRetained Earnings

BADGER METER INC

NYSE:BMI (11/5/2025, 8:04:00 PM)

After market: 186.19 0 (0%)

186.19

+3.11 (+1.7%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-21 2025-10-21/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners99.93%
Inst Owner Change-1.29%
Ins Owners0.51%
Ins Owner Change-0.18%
Market Cap5.49B
Revenue(TTM)901.14M
Net Income(TTM)138.78M
Analysts73.33
Price Target226.96 (21.9%)
Short Float %6.24%
Short Ratio4.8
Dividend
Industry RankSector Rank
Dividend Yield 0.88%
Yearly Dividend1.22
Dividend Growth(5Y)13.8%
DP30.1%
Div Incr Years18
Div Non Decr Years18
Ex-Date08-22 2025-08-22 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.02%
Min EPS beat(2)-7.6%
Max EPS beat(2)3.55%
EPS beat(4)2
Avg EPS beat(4)2.98%
Min EPS beat(4)-7.6%
Max EPS beat(4)21.92%
EPS beat(8)5
Avg EPS beat(8)4.65%
EPS beat(12)8
Avg EPS beat(12)6.34%
EPS beat(16)11
Avg EPS beat(16)6.98%
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)0.62%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)0.62%
Revenue beat(8)4
Avg Revenue beat(8)1.08%
Revenue beat(12)8
Avg Revenue beat(12)2.82%
Revenue beat(16)11
Avg Revenue beat(16)2.84%
PT rev (1m)-4.33%
PT rev (3m)-4.64%
EPS NQ rev (1m)1.74%
EPS NQ rev (3m)0.9%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-3.86%
Revenue NQ rev (1m)-1.57%
Revenue NQ rev (3m)-1.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 39.61
Fwd PE 34.39
P/S 6.09
P/FCF 32.99
P/OCF 30.32
P/B 7.81
P/tB 15.96
EV/EBITDA 24.33
EPS(TTM)4.7
EY2.52%
EPS(NY)5.41
Fwd EY2.91%
FCF(TTM)5.64
FCFY3.03%
OCF(TTM)6.14
OCFY3.3%
SpS30.58
BVpS23.84
TBVpS11.67
PEG (NY)2.87
PEG (5Y)1.87
Graham Number50.21
Profitability
Industry RankSector Rank
ROA 14.19%
ROE 19.75%
ROCE 21.77%
ROIC 16.43%
ROICexc 21.75%
ROICexgc 51.26%
OM 19.93%
PM (TTM) 15.4%
GM 41.26%
FCFM 18.45%
ROA(3y)13.08%
ROA(5y)12.25%
ROE(3y)17.86%
ROE(5y)16.46%
ROIC(3y)15.23%
ROIC(5y)14.23%
ROICexc(3y)23.61%
ROICexc(5y)20.43%
ROICexgc(3y)41.01%
ROICexgc(5y)36.17%
ROCE(3y)20.17%
ROCE(5y)18.85%
ROICexgc growth 3Y15.78%
ROICexgc growth 5Y16.08%
ROICexc growth 3Y21.65%
ROICexc growth 5Y15.12%
OM growth 3Y7.03%
OM growth 5Y5.49%
PM growth 3Y7.84%
PM growth 5Y6.34%
GM growth 3Y-0.7%
GM growth 5Y0.68%
F-Score5
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 43.31%
Cap/Sales 1.63%
Interest Coverage 250
Cash Conversion 84.78%
Profit Quality 119.84%
Current Ratio 3.22
Quick Ratio 2.23
Altman-Z 14.58
F-Score5
WACC9.17%
ROIC/WACC1.79
Cap/Depr(3y)34.99%
Cap/Depr(5y)33.03%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.55%
Profit Quality(3y)111.64%
Profit Quality(5y)126.18%
High Growth Momentum
Growth
EPS 1Y (TTM)16.63%
EPS 3Y26.69%
EPS 5Y21.16%
EPS Q2Q%10.19%
EPS Next Y13.79%
EPS Next 2Y13.14%
EPS Next 3Y10.48%
EPS Next 5Y12.18%
Revenue 1Y (TTM)12.11%
Revenue growth 3Y17.83%
Revenue growth 5Y14.25%
Sales Q2Q%13.06%
Revenue Next Year12.3%
Revenue Next 2Y10.4%
Revenue Next 3Y8.55%
Revenue Next 5Y9.3%
EBIT growth 1Y19.1%
EBIT growth 3Y26.12%
EBIT growth 5Y20.53%
EBIT Next Year36.93%
EBIT Next 3Y16.39%
EBIT Next 5Y15.62%
FCF growth 1Y83.29%
FCF growth 3Y20.76%
FCF growth 5Y14.2%
OCF growth 1Y77.62%
OCF growth 3Y21%
OCF growth 5Y13.95%

BADGER METER INC / BMI FAQ

What is the fundamental rating for BMI stock?

ChartMill assigns a fundamental rating of 7 / 10 to BMI.


What is the valuation status of BADGER METER INC (BMI) stock?

ChartMill assigns a valuation rating of 3 / 10 to BADGER METER INC (BMI). This can be considered as Overvalued.


Can you provide the profitability details for BADGER METER INC?

BADGER METER INC (BMI) has a profitability rating of 9 / 10.


What are the PE and PB ratios of BADGER METER INC (BMI) stock?

The Price/Earnings (PE) ratio for BADGER METER INC (BMI) is 39.61 and the Price/Book (PB) ratio is 7.81.


Can you provide the dividend sustainability for BMI stock?

The dividend rating of BADGER METER INC (BMI) is 6 / 10 and the dividend payout ratio is 30.1%.